Recombinant Casein Micelle Assembly in Plant Cells
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The industrial-scale production of casein micelles from bovine milk is inefficient, environmentally damaging, and harmful to dairy cows, necessitating a cost-effective, plant-based alternative for the purification of biologically active casein proteins.
Innovation Solution
A method for in vivo assembly of recombinant micelles in plant cells involves introducing a plasmid with DNA segments encoding proteins for casein micelles, resulting in the formation of recombinant casein proteins and their assembly into micelles within the plant cell, with an outer layer enriched with κ-casein and an inner matrix containing αS1-casein, αS2-casein, and β-casein.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If industrial-scale production uses bovine milk processing, then casein micelles can be produced, but the process is inefficient and environmentally damaging
Solution Approach 1:
The patent creates a synthetic biological system that copies the natural casein micelle formation process but uses plant cells instead of bovine milk. The plasmid contains DNA sequences that encode casein proteins, which are expressed in plant cells to form micelles, thereby copying the functional outcome without the harmful environmental impact of industrial dairy farming
Solution Approach 2:
The patent replaces the mechanical/industrial milk processing system with a biological system using plant cells. Instead of mechanically processing bovine milk, the system uses genetic engineering to produce casein proteins within plant cell structures, substituting industrial machinery with biological processes
2Productivity
If industrial-scale production uses bovine milk processing, then casein micelles can be produced, but it is harmful to dairy cows
Solution Approach 1:
The patent copies the casein micelle production function but transfers it from bovine to plant systems. The plasmid encoding casein proteins is introduced into plant cells, allowing the same functional outcome (casein micelle formation) without subjecting animals to harmful practices like dehorning, disbudding, mastitis, and forced insemination
Solution Approach 2:
The patent uses plant cells as an intermediary system to produce casein micelles. Instead of directly processing bovine milk, the system uses plants as a mediator that can be genetically engineered to express casein proteins, thereby eliminating the harmful impact on dairy cows while maintaining production capability
3Object-generated harmful factors
If plant-based casein expression system is used, then environmental impact is reduced, but purification of biologically active casein proteins becomes challenging
Solution Approach 1:
The patent employs feedback mechanisms in the form of selectable markers and screenable traits that enable monitoring and selection of plant cells successfully expressing the casein micelle plasmid. This feedback system ensures that only cells producing the desired proteins are selected, maintaining high purification quality despite the alternative production system
Solution Approach 2:
The patent utilizes parameter changes in plant cell physiology and gene expression to optimize casein protein production. By controlling conditions such as tissue type, developmental stage, and environmental factors, the system achieves high yields of biologically active casein proteins suitable for industrial purification
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables the cost-effective, industrial-scale purification of biologically active casein proteins in a plant-based system, reducing environmental impact and animal welfare concerns while maintaining the biological activity of the casein proteins.
Implementation Method 1
the segment of DNA is transcribed and translated
Implementation Method 2
the segment of DNA is transcribed and translated
Implementation Method 3
assembling in vivo a recombinant micelle within the plant cell
Data Source
AI summary
A method of in vivo assembly of a recombinant micelle including: introducing a plasmid into a plant cell, wherein: the plasmid includes a segment of deoxyribonucleic acid (DNA) for encoding a ribonucleic acid (RNA) for a protein in a casein micelle, the segment of DNA is transcribed and translated; forming recombinant casein proteins in the plant cell, wherein: the recombinant casein proteins include a κ-casein and at least one of an αS1-casein, an αS2-casein, a β-casein; and assembling in vivo a recombinant micelle within the plant cell, wherein: an outer layer of the recombinant micelle is enriched with the κ-casein, an inner matrix of the recombinant micelle include at least one of the αS1-casein, the αS2-casein, the β-casein.